Chorioamnionitis
24
3
3
11
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.3%
2 terminated out of 24 trials
84.6%
-1.9% vs benchmark
8%
2 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (24)
IL-6 and Lactates in Cord Blood and Neonatal Outcomes
Amniotic Fluid & the Preterm Gut
Treatment of Chorioamnionitis After Delivery
Comparing Infectious Morbidity Among Women With Meconium-stained Amniotic Fluid at Term, Between Those Treated With Prophylactic Antibiotics Zinacef vs. Placebo
Antipyretic Treatment for Intrapartum Fever: Dipyrone vs Acetaminophen (RCT)
Selective Use of Antibiotics in Neonates Born to Mothers With Suspected Chorioamnionitis
Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy
Management of Prelabor Rupture of the Membranes at Term
Effect of Sterile Versus Clean Gloves Intrapartum and Postpartum Infections at Term
Circulating Markers in Preterm Infants With Perinatal and Neonatal Inflammation
Safety of N-acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio)
Assessment of Labour Progress by Intrapartum Ultrasound
Chorioamnionitis: Observation of at Risk Infants vs Standard Care
Intrapartum Fever: Antibiotics Versus no Treatment
N-acetylcysteine in Intra-amniotic Infection/Inflammation
Effect of Chorioamnionitis on Platelet Activation and Placental Vessel Among Preterm Infants by Wnt-Flt1 Signal Pathway
Intrapartum Study of Sterile and Clean Gloves
Ampicillin / Sulbactam vs. Ampicillin / Gentamicin for Treatment of Chorioamnionitis
Closure of Skin in ChorioAmnionitis Research Pilot Study
Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term